参麦注射液升白细胞作用的临床疗效观察

目的:观察参麦注射液升白细胞作用的安全性及有效性,评价参麦注射液的应用价值。方法:将60例癌症化疗患者随机分为治疗组(参麦组)40例和对照组(惠尔血组)20例。治疗组在每一个化疗周期的前一周给予参麦注射液100mL加入到5%GS250mL中静滴,qd,连用15天;对照组在化疗期间根据血常规检验结果,当WBC≤3·0G/L时给予惠尔血75μg于皮下注射,待WBC≥10·0G/L时停药。结果:参麦组的升白细胞作用为100%,且所有病例均按时完成化疗计划;惠尔血组升白效果100%,但呈波动性变化,且有12例患者伴有周身剧痛。结论:参麦注射液升白细胞作用优于惠尔血,表现在作用持久、温和、安全、有效,临床无毒副作用。

Clinical Effect of Shen Mai Injection on White Blood Cell Increase

Objective: To observe the safety and effectiveness of Shen Mai Injection in increasing white blood cells (WBCs) and evaluate its value in application.Method:60 cancer patients under chemotherapy were randomly classified into two groups: 40 in Group One were treated by Shen Mai Injection and 20 in Group Two by Recombinant Human Granulocyte Colony Stimulating Factor Injection (rhG-CSF). A week before a chemotherapy period, 100ml of Shen Mai Injection was added to 250mL of 5% GS and intravenously dripped to each patient in Group One everyday for 15 days. Patients in Group Two were given routine blood tests during their chemotherapy. When WBC was≤3.0G/L,75μg rhG-CSF was hypodermically injected to the patients until WBC was≥I0.0G/L. Result: WBC sincreased in all the patients in Group One, who finished their chemotherapy on schedule. WBCs also increased in all the patients in Group Two, but 12 of them had sharp pain all over their bodies. Conclusion: In terms of WBC increase, the effect of Shen Mai Injection is better than that of rhG-CSF, in that Shen Mai Injection presents a longer, safer, tenderer, and more effective result.